
Just how radical is the FDA's complete response letter move?
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.


Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.

Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

On nuclear medicine and oncology, SHINE technologies
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.

Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.

16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference

Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This